Document is current
Any future updates will be listed below
-
Authors
Hallé, Eléonore
Azahaf, Mustapha
Duveau, Nicolas
Lambin, Thomas
Nachury, Maria
Branche, Julien
Gérard, Romain
Lauriot Dit Prevost, Clémentine
Wils, Pauline
Desreumaux, Pierre
Ernst, Olivier
Pariente, Benjamin
- License Information
-
More Information
Article History
Received: 20 May 2019
Accepted: 27 November 2019
First Online: 6 December 2019
Compliance with Ethical Standards
:
: N. Duveau: Lecture fees: Takeda. T.Lambin: Travel accommodation: Adacyte. M. Nachury: Lecture fees: Abbvie MSD Takeda Janssen Pfizer Ferring. Boards: Janssen, Boehringer-Ingelheim, Biogen. C. Lauriot Dit Prevost: Travel accommodation: Takeda, Hospira, Pfizer, MSD. P. Wils: Lecture fees: takeda, ferring travel accommodation: Janssen, hospira, biogaran. P. Desreumaux: Consulting fees: Biofortis, Ferring, Roquette, UCB Pharma, Lesaffre, MSD, Abbott, Norgine, Genfit, OmegaPharma International, Ppm, Kitozyme, LFB, Takeda, Boehringer Ingelheim, Intralytix USA, Janssen, Biose, Ingredia. Lecture fees: Ferring, Shire Pharmaceuticals, UCB Pharma, MSD, Norgine, Abbott, Janssen, Norgine, Tillotts, Takeda, Abbvie Biocodex, Jaldes. B. Pariente: Consulting fees: AbbVie, MSD, Takeda, Janssen, Lilly, Pfizer, and Biogaran. Lecture fees: Abbvie, MSD, Takeda, Janssen, and Ferring, and other authors declare that they have no conflict of interest.
